Novo Holdings considers sale of Xellia Pharmaceuticals
![Photo: Xellia Pharmaceuticals PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article8242201.ece/ALTERNATES/schema-16_9/Xellia%2520manufacturing-version3.jpg)
Sources have told Bloomberg News that Novo Holdings is currently investigating its options for a possible sale of Xellia Pharmaceuticals, which is headquartered in Amager, Copenhagen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.